Cohort Event Monitoring Study of Pyramax®

PHASE4CompletedINTERVENTIONAL
Enrollment

8,572

Participants

Timeline

Start Date

June 22, 2017

Primary Completion Date

April 10, 2019

Study Completion Date

April 10, 2019

Conditions
Malaria,Falciparum
Interventions
DRUG

pyronaridine artesunate

Antimalarial treatment

Trial Locations (5)

Unknown

The Biotechnology Center Nkolbisson, Univ of Yaounde I, Messa, Yaoundé

Centre de Santé FCRM, Hospital of Talangai, Brazzaville

BP 1500

Institut Pierre Richet / Institut National de SanPublique (IPR/INSP), Bouaké

XI

Centre de Recherche du Centre Hospitalier du Mont Amba, Kinshasa

BP 118

CERMEL, Albert Schweitzer Hospital, Lambaréné

All Listed Sponsors
collaborator

Medicines for Malaria Venture

OTHER

lead

Shin Poong Pharmaceutical Co. Ltd.

INDUSTRY

NCT03201770 - Cohort Event Monitoring Study of Pyramax® | Biotech Hunter | Biotech Hunter